DeepMatter Plc is based in Glasgow and is quoted on the Alternative Investment Market (AIM). The group has developed DigitalGlasswareTM, an artificial intelligence-enabled cloud-based software and hardware platform allowing chemistry experiments to be accurately and systematically recorded, coded and entered into a shared data cloud. This enables chemists to work together effectively, sharing the details of their experiments from anywhere and in real time, to help avoid work being needlessly duplicated, and ultimately so new discoveries may be made faster.

Synthetic Chemistry to support drug discovery therapeutics has not evolved over hundreds of years. The digitization of chemistry by collecting rich data using their sensors, which then can be analysed through machine learning could disrupt the chemical information industry. Predicting the optimal conditions for a reaction to proceed or whether a reaction is doomed to fail with the press of a button could save this multi-billion dollar industry significant time and money. The acquisition of InfoChem GmbH based in Munich, Germany from global publisher Springer Nature, will help DeepMatter accelerate their plans providing them with specialist staff, recurring revenue and an additional sales channel.